Navigation Links
Gentris Corporation Opens New Genomic Biomarker Laboratory in China
Date:11/20/2013

MORRISVILLE, N.C., Nov. 20, 2013 /PRNewswire/ -- Gentris® Corporation (www.gentris.com), a global leader in the application of genomic biomarkers to clinical studies, announced today that it has opened a new genomic biomarker testing and biorepository services laboratory in Shanghai, China. Gentris Shanghai will provide GCLP-compliant testing and biobanking services for global pharmaceutical clients under international standards.

(Logo: http://photos.prnewswire.com/prnh/20130916/CL80771LOGO )

"The launch of Gentris Shanghai is a tremendous milestone for our company," said Dr. Amelia Wall Warner, Gentris President and CEO. "Gentris is creating an international quality, global organization capable of providing genomic biomarker testing and biobanking services for clinical trials. In addition to commercial services, we are building collaborations with top Chinese research organizations, universities, and companies to accelerate drug development and innovation."

Gentris Shanghai will solve a critical need for pharmacogenomic (PGx) testing and clinical sample storage under international standards in China. Drug developers increasingly conduct large, integrated clinical trials that span the globe. China has been a primary focus in recent years due to a rapidly growing economy and tremendous investments in pharmaceutical, biotechnology, and innovation infrastructure. Gentris Shanghai provides the necessary services and expertise to conduct PGx-enabled clinical trials in China and accelerate drug development globally.

"This is an exciting time for Gentris as we expand into China, which is now the third largest pharmaceutical market in the world," said Dr. Tong Zhou, Gentris Shanghai General Manager. "Our sponsors are increasingly incorporating China into global clinical trials and we are working with them to meet a critical need for harmonized, international standards for biobanking and genomic biomarker testing."

Initial services will include biobanking and nucleic acid prep. Genotyping and gene expression services will launch in 2014 with phased implementation based on market demand.

Gentris Shanghai is also working closely with government organizations, medical researchers, and hospitals to create translational research, education, and training collaborations focused on genomic biomarker testing and biobanking that will drive innovation in drug development and patient care. For example, Gentris, the Shanghai Institutes of Preventative Medicine, and an independent research institute are conducting a study to collect and analyze biospecimens from tuberculosis patients in China to evaluate drug-induced liver injury and potential biomarkers. By working with Gentris and its collaborators, industry sponsors will be able to gain access to unique clinical samples, patient populations, and new technology in China.

Related Links: www.gentris.com

About Gentris Corporation:
Founded in 2001, Gentris is located in Research Triangle Park, NC, where it provides pharmacogenomics and biorepository support for all phases of clinical studies and genomic biomarker programs. The company works with academic and industry leaders to translate innovations in pharmacogenomics into safer, more effective medicines, which can lead to accelerated drug development and improvement in patient care globally. In the past year, Gentris has significantly expanded its facility and onsite biorepository to meet the increased needs of biopharma clients, while maintaining a preeminent quality system.

About Gentris Shanghai
Gentris Shanghai builds on over 10 years of genomic biomarker testing and biorepository services in the USA. The company was created from the ground up to ensure the highest quality services performed under international regulatory standards. The mission of Gentris Shanghai is to enable globally-integrated pharmacogenomics drug development studies in China. In addition to commercial services, Gentris Shanghai has built relationships with leading research organizations, hospitals, universities, and government agencies in China in order to facilitate collaborations and partnerships that can accelerate innovation and improve patient care globally.


'/>"/>
SOURCE Gentris Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Gentris Corporation Partners with the Shanghai Institutes of Preventative Medicine
2. Gentris Corporation Launches New Pharmacogenomics Services
3. Gentris Corporation Announces Collaboration to Study Blood Stability
4. Gentris Corporation Expands Headquarters, Biorepository
5. Gentris Integrated Biorepository Receives Accreditation From The College of American Pathologists
6. Gentris Corporation Launches Next Generation Human Transcriptome Array
7. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
8. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
9. Richard Wolf Medical Instruments Corporation: 40 Years of Innovation
10. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
11. Luminex Corporation Reports First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding ... identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to ... the need to turn on a light when taking medication during the night, allowing ...
(Date:10/13/2017)... ... October 13, 2017 , ... Southern ... and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice Frueh, ... cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU School ...
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
Breaking Medicine News(10 mins):